Constellation Pharmaceuticals (CNST) PT Raised to $53 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Brian Abrahams raised the price target on Constellation Pharmaceuticals (NASDAQ: CNST) to $53.00 (from $45.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
